Eli Lilly warns of safety risks in knockoff weight-loss drugs
Reliability
Corroborated
Based on 3 sources
Source Diversity
Major Media (3)
Publications (2)
Sources (3)Fact-Checking
14 claimsOpen Questions
5 questionsWhat specific impurities were found in the compounded tirzepatide-B12 products?
How many adverse events have been reported from compounded tirzepatide-B12 products?
What decisive steps will the FDA take to restrict the sale of non-FDA-approved compounded weight-loss drugs?
Which specific entities are continuing to mass-compound tirzepatide despite FDA and court orders?
What are the exact health risks posed by the impurities in compounded tirzepatide-B12 products?
This article was produced by Reed News using AI. All claims are cross-referenced against multiple sources.